ONCOPL Dispositif spécifique régional du cancer

What ONCOPL Dispositif spécifique régional du cancer does

ONCOPL (Dispositif Spécifique Régional du Cancer) is a nonprofit regional cancer care coordination network serving Pays de la Loire, France, headquartered in Nantes. Founded in 2002 and re-labeled by the Institut National du Cancer (INCa) as an official DSRC in March 2022, it operates under institutional financing from the Agence Régionale de Santé (ARS) Pays de la Loire. The organization coordinates cancer care across the region by connecting hospitals, 3C (Centres de Coordination en Cancérologie) centers, HAD (Hospitalisation à Domicile) providers, oncologists, geriatricians, pediatric oncologists, and patient associations, and provides services free of charge to healthcare professionals in the region. It is led by Director and Medical Coordinator Fabienne Empereur, with Pr Mario Campone serving as President, supported by a small team of seven employees plus specialized project managers.

ONCOPL's core technology platform is the DCC ONCOPL (Dossier Communicant de Cancérologie), a digital cancer patient record system enabling medical information sharing and care coordination among authorized professionals. The platform has undergone continuous version updates — v5.0 in September 2023, v5.2 through v5.7 across 2024–2025, and v6.2 in March 2026 — hosted via a dedicated portal (portail.mediware.fr). Beyond the DCC, ONCOPL maintains an ecosystem of clinical decision-support tools: ONCOACCESS (directory of molecules available via derogation access), the Répertoire des référentiels (curated clinical guidelines from INCa, ESMO, ASCO), the Annuaire des RCP (multidisciplinary meeting directory), side-effect directories and oral-chemotherapy information sheets in partnership with OMEDIT Pays de la Loire, PRONCOPED (a dedicated digital binder for pediatric oncology), and the La Minute Oncofertilité web series for fertility preservation in oncology. Specialized pathways cover oncogeriatrics (UCOGpl), oncopediatrics (ONCOPEDpl), and oncogenetics. Marketing channels consist primarily of the website, regional conference days, webinars, and a Facebook presence.

The business model is that of a publicly-funded regional health network rather than a commercial enterprise. There is no product pricing, no disclosed revenue, no funding rounds, and no private equity involvement. ONCOPL is financed by ARS Pays de la Loire as part of its official DSRC mandate, supplemented by event sponsorship from pharmaceutical companies (Daiichi Sankyo, Merck, MSD, Novartis, Servier, Viatris, Boiron, Nutricia, Novocure, Oxypharm, Resilience, Handipharm) for annual regional days. The organization holds GDPR/Loi Informatique et Libertés compliance for all data processing, and participates in national DCC evolution projects with INCa and ANS. Geographic scope is strictly regional, with no disclosed expansion plans beyond Pays de la Loire.

Name

ONCOPL Dispositif spécifique régional du cancer

Legal name

ONCOPL - Dispositif spécifique régional du cancer

Website

https://oncopl.fr

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Regional Cancer Care Coordination Services

NAICS

Offices of Physicians (62111)

SIC

Services-Health Services (8000)

akta.pro primary industry

Oncology Telemedicine Platforms (HLALAGAH)

akta.pro secondary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Regional cancer coordination
• Oncology care network
• Digital cancer patient record
• Clinical guidelines directory
• Healthcare professional coordination

Headquarters

HQ city

Nantes

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels3 records

Marketing channels4 records

Core offering

ONCOPL coordinates cancer care across the Pays de la Loire region of France as the official DSRC (Dispositif Spécifique Régional du Cancer), funded by the regional health agency (ARS). It deploys and supports the DCC (Dossier Communicant de Cancérologie) digital patient record, maintains directories of clinical guidelines, side-effect sheets, RCP meetings, and healthcare resources, and organizes training and webinars for oncology professionals.

Product overview

ONCOPL is a regional cancer coordination network (Dispositif Spécifique Régional du Cancer) for Pays de la Loire, France, operating as a unified service platform centered on the DCC ONCOPL (Dossier Communicant de Cancérologie) digital health record system. The organization provides a comprehensive suite of tools including the DCC platform for patient data coordination, ONCOACCESS for molecule access information, multiple reference directories ( référentiels, ressources, RCP), side effect management tools (Fiches effets secondaires, Répertoire des effets secondaires), fertility preservation resources (including the La Minute Oncofertilité web series and technical guides), PRONCOPED for pediatric oncology, and DCC tutorial videos. The ecosystem is organized around care pathways for general oncology, oncogeriatrics (UCOGpl), and oncopediatrics (ONCOPEDpl), all supported by the core DCC digital infrastructure.

Differentiator

Problem solved

Functional benefit

Products and services

• DCC ONCOPL (Dossier Communicant de Cancérologie) Digital health record platform enabling cancer care professionals across the Pays de la Loire region to coordinate patient care, share medical information between hospital and primary care, and participate in multidisciplinary team meetings (RCP).
• ONCOACCESS Directory of cancer therapies available through special access programs, organized by tumor location, for use by regional oncology professionals.
• Répertoire des effets secondaires (UCOGpl) Directory of cancer treatment side effects organized by cancer type (digestive, breast, urological) with specific guidance for elderly patients, for use by oncology and geriatric professionals.
• Fiches effets secondaires voies orales Information sheets on oral cancer treatment side effects for healthcare professionals, provided in partnership with OMEDIT Pays de la Loire.
• Préservation de la fertilité en contexte oncologique Comprehensive regional fertility preservation toolkit for oncology, including directories of approved AMP centers, liaison forms, logigrams for different patient groups, and information sheets.
• La Minute Oncofertilité (Web-série) Web series of short videos (15 episodes) addressing fertility preservation questions for oncology professionals and patients.
• Annuaire des référentiels Directory of clinical practice guidelines and references organized by organ type and treatment modality for oncology professionals.
• Annuaire des ressources Directory of healthcare resources in Pays de la Loire, including authorized cancer establishments, 3C centers, HAD services, patient associations, and other health facilities.
• Annuaire des RCP Regional directory of Multidisciplinary Team Meetings (Réunions de Concertation Pluridisciplinaire) for cancer case discussions across the Pays de la Loire region.
• PRONCOPED Dedicated binder/folder for pediatric oncology professionals providing coordinated care information for young cancer patients in the region.
• Tutos DCC Video tutorials to facilitate use of the DCC cancer digital health record by regional healthcare professionals.

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

17 partnerships are on record, tiered minor, moderate and core.

• Daiichi SankyominorGTM or Marketing PartnerPrivate partner for the ONCOPL 2026 regional day on city-hôpital coordination, providing sponsorship support.
• MerckminorGTM or Marketing PartnerPrivate partner for the ONCOPL 2026 regional day on city-hôpital coordination, providing sponsorship support.
• MSD (MDS)minorGTM or Marketing PartnerPrivate partner for the ONCOPL 2026 regional day on city-hôpital coordination, providing sponsorship support.
• NovartisminorGTM or Marketing PartnerPartner for both the ONCOPL 2026 regional day and the Cancer et Personne Agée 2026 day, providing sponsorship support.
• OxypharmminorGTM or Marketing PartnerPrivate partner for the ONCOPL 2026 regional day on city-hôpital coordination, providing sponsorship support.
• ResilienceminorGTM or Marketing PartnerPrivate partner for the ONCOPL 2026 regional day on city-hôpital coordination, providing sponsorship support.
• ViatrisminorGTM or Marketing PartnerPartner for both the ONCOPL 2026 regional day and the Cancer et Personne Agée 2026 day, providing sponsorship support.
• BoironminorGTM or Marketing PartnerPartner for the Cancer et Personne Agée 2026 regional day, providing sponsorship support.
• HandipharmminorGTM or Marketing PartnerPartner for the Cancer et Personne Agée 2026 regional day, providing sponsorship support.
• NovocureminorGTM or Marketing PartnerPartner for the Cancer et Personne Agée 2026 regional day, providing sponsorship support.
• Nutricia (Danone)minorGTM or Marketing PartnerPartner for the Cancer et Personne Agée 2026 regional day, providing sponsorship support.
• ServierminorGTM or Marketing PartnerPartner for the Cancer et Personne Agée 2026 regional day, providing sponsorship support.
• Ligue contre le cancer - CD 44moderateStrategic or Co-development PartnerAssociative partner for the ONCOPL 2026 regional day, representing patient advocacy in cancer care.
• Ligue contre le cancer - CD 72moderateStrategic or Co-development PartnerAssociative partner for the ONCOPL 2026 regional day, representing patient advocacy in cancer care.
• OMEDIT Pays de la LoiremoderateStrategic or Co-development PartnerPartner organization providing oral chemotherapy side effect sheets for healthcare professionals through the ONCOPL platform.
• INCa (Institut National du Cancer)coreStrategic or Co-development PartnerNational cancer institute providing guidelines, recommendations, and organizational standards that ONCOPL disseminates regionally. ONCOPL participates in national DCC evolution projects with INCa and ANS.
• Cancéropôle Grand OuestmoderateStrategic or Co-development PartnerInter-regional cancer research organization providing mobility grants and calls for projects that ONCOPL shares with regional professionals.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• ONCO Grand Est: DSRC for the Grand Est region, performing equivalent regional cancer care coordination functions under the INCa DSRC framework with the same ARS funding model, DCC platform deployment, and care pathway coordination services as ONCOPL.
• ONCO Bretagne (Réseau de cancérologie de Bretagne): DSRC for the Bretagne region, operating a comparable regional cancer coordination platform with similar services including DCC deployment, RCP directories, and clinical guidelines dissemination. Geographically adjacent to ONCOPL's Pays de la Loire region.
• ONCO Nouvelle-Aquitaine: DSRC for the Nouvelle-Aquitaine region providing regional cancer care coordination under the same INCa framework as ONCOPL, including DCC deployment, RCP support, and clinical practice guidelines dissemination to regional oncology professionals.
• ONCO Hauts-de-France: DSRC for the Hauts-de-France region with the same INCa-recognized mandate to coordinate cancer care, support RCPs, deploy the DCC digital health record, and provide continuing education to oncology professionals, paralleling ONCOPL's role in Pays de la Loire.
• ONCORIF (Réseau de cancérologie d'Île-de-France): DSRC for the Île-de-France region, operating under the same INCa designation model as ONCOPL with parallel responsibilities for cancer care coordination, DCC deployment, and professional education. Direct peer due to identical mandate, funding model, and service portfolio across a different French region.
• ONCOPACA (Réseau régional de cancérologie PACA): DSRC for the Provence-Alpes-Côte d'Azur region, performing the same regional cancer coordination role as ONCOPL with equivalent ARS funding, DCC deployment responsibilities, and professional education mandate under the INCa framework.
• ONCO Occitanie: DSRC for the Occitanie region with parallel cancer care coordination mandate under the INCa framework, providing equivalent services including DCC deployment, RCP directories, professional guidelines, and care pathway coordination across a different French region.
• ONCO AURA (Réseau de cancérologie Auvergne-Rhône-Alpes): DSRC for the Auvergne-Rhône-Alpes region, with the same INCa-recognized mandate to coordinate cancer care, deploy the DCC, and provide RCP support and clinical guidelines. Directly comparable to ONCOPL in mandate, business model, and service offering across a different French region.

Broad incumbents

• Unicancer: French federation of cancer centers (CLCCs) coordinating oncology activities at the national level. Comparable as a broader oncology ecosystem organization operating in the same space as ONCOPL, with overlapping stakeholder network including CHU Nantes and ICO Nantes that participate in ONCOPL's regional coordination.
• INCa (Institut National du Cancer): French national cancer agency that designates DSRCs like ONCOPL, sets national standards, and funds the regional cancer network ecosystem. Comparable as the national-level incumbent that defines ONCOPL's mandate, provides guidelines, and co-funds DCC evolution projects.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/ONCOPL
• LinkedInlinkedin.com/company/oncopl

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ONCOPL Dispositif spécifique régional du cancer